Retail Clinics

  • New blood-pressure monitor connects to Apple devices

    LAS VEGAS — A designer and manufacturer of digital personal healthcare products has launched a blood-pressure monitoring system for the Apple iPhone, iPod Touch and iPad.

    IHealth Lab's iHealth blood-pressure monitoring system lets users measure and track their blood pressure and heart rate.

  • Collaborative care alchemy: Pharmacists + nurses = gold

    

Last month, the American Journal of Managed Care published a review of more than 40 years worth of studies from various medical journals that demonstrated that the best way to improve adherence is to get patients to talk to the store pharmacist; the second-best way is to get them to talk to a nurse before they leave the hospital.


  • Sam's Club starts new year with new health services

    BENTONVILLE, Ark. — Sam's Club announced that it is offering its business, advantage and plus members tools to help them achieve their health goals, including free monthly, in-club health screenings and access to a new health management benefit, The Prevention Plan, from U.S. Preventive Medicine.

  • Report: Intel to open worksite clinic for employees

    HILLSBORO, Ore. — Intel is helping its employees gain convenient access to health care with the opening this week of an on-site medical center at its Jones Farm Campus in Hillsboro, which will be operated by Walgreens' Take Care Health Systems, according to local news reports.

    Later this year, Intel is looking to open a second worksite medical clinic at is Ronler Acres Campus, according to reports.

  • Glenmark gets FDA OK for three drugs

    MUMBAI, India — The Food and Drug Administration approved three drugs made by Glenmark Generics last month and gave tentative approval to a fourth, the Indian generic drug maker said.

  • Report: More than a quarter of U.S. kids take at least one chronic med

    NEW YORK — More than 25% of children and teens take at least one medication on a daily basis, and nearly 7% are on two or more drugs, the Wall Street Journal reported Tuesday, citing 2009 data from Medco Health Solutions. Drawing additional data from IMS Health, the article noted that prescriptions for hypertension in people under the age of 20 years could reach 5.5 million for 2010 by the time year-end results are tabulated, which would mark a rise of 17% since 2007. 

  • New IRS guidance allows continued use of FSA/HRA debit cards to pay for OTCs

    WASHINGTON — Though most might associate the Internal Revenue Service with the Grinch, the IRS came through with a last-minute Christmas present for retailers stung by changes in the tax code related to consumers’ use of flexible spending and health reimbursement accounts to purchase approved OTC products.

  • Bartell donates flu vaccines to help community outreach programs through local schools of pharmacy

    SEATTLE — In an effort to help people in local underserved communities and students in need stay well this flu season, Bartell Drugs will give 4,000 flu vaccines to the University of Washington and Washington State University for use in pharmacy programs at both universities. Each school will receive 2,000 doses of the current flu vaccines to support local student pharmacy outreach programs.

  • FDA approves Merck's Gardasil for prevention of anal cancer

    WHITEHOUSE STATION, N.J. — Merck on Wednesday announced that the Food and Drug Administration has approved Gardasil [human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant] for the prevention of anal cancer in males and females 9 to 26 years of age.

    According to the company, Gardasil is the first HPV vaccine on the market available for use in both men and women, and the only one indicated  to help prevent cervical, vaginal, vulvar and anal cancers and pre-cancers, as well as genital warts, caused by certain types of HPV.

  • FDA approves Watson oral contraceptive

    MORRISTOWN, N.J. — The Food and Drug Administration has approved the first and only low-dose oral contraceptive to combine 0.8-mg norethindrone and 0.025-mg ethinyl estradiol in a chewable form, with four 75-mg ferrous fumarate (iron) placebo tablets, Watson Pharmaceuticals has announced.

    Watson's new oral contraceptive is positioned as a novel alternative to currently available birth control pills, and the dosing combination and 24-day active hormone regimen is intended to provide users with a low level of breakthrough bleeding and short, light, predictable periods.

X
This ad will auto-close in 10 seconds